Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at email@example.com if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
This comprehensive resource covers product change evaluation, postmarket surveillance, audit/inspection compliance, and various other laws and regulations pertaining to maintaining a product on the market.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
| 01 August 2013 | By Louise Zornoza
Australia's Therapeutic Goods Administration has released an outline of its goals in the international arena for the next three years. The International Engagement Strategy 2013-2015 links current Australian priorities for international engagement that are necessary to support effective therapeutic goods regulation with the TGA's day-to-day activities and sets clear goals for international engagement activities.
Those activities include:
TGA stresses that achieving these goals will require strategic and coordinated investment in terms of resources, harmonization projects, attending international meetings, and greater reliance on the expertise and resourcing opportunities available throughout the government. At the same time, the agency also recognizes possible obstacles to the effective delivery and implementation of activities under its International Engagement Strategy, such as differences in international regulatory approach, failure to agree common international standards, inability to share unredacted information between regulators, and limited access to post-market monitoring information, as well as the agency's own Blueprint reform agenda and workload for the establishment of ANZTPA.
Read all Breaking News from RegLink